Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Helene D. Clayton-Jeter"'
Autor:
Keith C. Ferdinand, Dennis R. Cryer, Samar A. Nasser, Helene D. Clayton-Jeter, John C. Lewin, Robert M. Califf, Fortunato Fred Senatore, Mona Fiuzat
Publikováno v:
Journal of the American College of Cardiology. 69:437-451
Medication nonadherence, a major problem in cardiovascular disease (CVD), contributes yearly to approximately 125,000 preventable deaths, which is partly attributable to only about one-half of CVD patients consistently taking prescribed life-saving m
Autor:
J. Gerry Kenna, Elizabeth Baker, Lorna Ewart, J. Lowry Curley, Jane M. Gunther, Bruce A. Donzanti, Helene D. Clayton-Jeter, Michael N. Liebman, Catherine L. Pugh, Paul B. Watkins, Kristie Sullivan, Nancy Beck, Edward L. LeCluyse, Ellen L. Berg, P. Charukeshi Chandrasekera
Publikováno v:
Drug discovery today. 24(2)
Nonclinical tests are considered crucial for understanding the safety of investigational medicines. However, the effective translation from nonclinical to human application is limited and must be improved. Drug development stakeholders are working to
Autor:
Fortunato Fred Senatore, Samar A. Nasser, Keith C. Ferdinand, John C. Lewin, Dennis R. Cryer, Kapil Yadav, Helene D. Clayton-Jeter
Publikováno v:
J Clin Hypertens (Greenwich)
Blacks are two to three times as likely as whites to die of preventable heart disease and stroke. Declines in mortality from heart disease have not eliminated racial disparities. Control and effective treatment of hypertension, a leading cause of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3471edcdcf1d167344c62b1f02c88e71
https://europepmc.org/articles/PMC5638710/
https://europepmc.org/articles/PMC5638710/
Autor:
Robert H. Beekman, Robert M. Nelson, Norman Stockbridge, Helene D. Clayton-Jeter, William R. Morrow, Geoffrey L. Rosenthal, David L. Wessel, Kathy J. Jenkins, D. Dunbar Ivy, Mary Dianne Murphy, Craig A. Sable, William T. Mahle
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 10
T he STARTS-1 and -2 trials (Sildenafil in Treatment-Naive Children, Aged 1 to 17 Years, With Pulmonary Arterial Hypertension) and subsequent 2012 US Food and Drug Administration (FDA) product labeling for sildenafil use in pediatric patients with pu
Autor:
Mary Rosedale, Shiela M. Strauss, David Rindskopf, Sherry Deren, Helene D. Clayton-Jeter, Marlena Vega
For Latinas with fasting plasma glucose (FPG) levels in the prediabetes and diabetes ranges, early detection can support steps to optimize their health. Data collected in 2009-2010 indicate that 36.7% of Latinas in the United States had elevated FPG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122258297217ca4268e4093146da6bcd
https://europepmc.org/articles/PMC5604331/
https://europepmc.org/articles/PMC5604331/